Synonyms: Adifax® | Fintepla® | Pondimin® | ZX008
fenfluramine is an approved drug (FDA (2020))
Compound class:
Synthetic organic
|
|
References |
1. Connolly HM, Crary JL, McGoon MD, Hensrud DD, Edwards BS, Edwards WD, Schaff HV. (1997)
Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med, 337 (9): 581-8. [PMID:9271479] |
2. Erickson JD, Schafer MK, Bonner TI, Eiden LE, Weihe E. (1996)
Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter. Proc Natl Acad Sci USA, 93 (10): 5166-71. [PMID:8643547] |
3. Mitchell P, Hickie I, Torda T. (1992)
Propofol and ECT. Br J Psychiatry, 161: 861-2. [PMID:1307869] |
4. Pierce JG, Mithal DS. (2020)
Fenfluramine: New Treatment for Seizures in Dravet Syndrome. Pediatr Neurol Briefs, 34: 8. [PMID:32189958] |
5. Vickers SP, Dourish CT, Kennett GA. (2001)
Evidence that hypophagia induced by d-fenfluramine and d-norfenfluramine in the rat is mediated by 5-HT2C receptors. Neuropharmacology, 41 (2): 200-9. [PMID:11489456] |